To include your compound in the COVID-19 Resource Center, submit it here.

Endo's axomadol misses back pain endpoint

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) said oral axomadol missed undisclosed pre-determined

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE